Literature DB >> 1563770

Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys.

C C Peeters1, D Evenberg, P Hoogerhout, H Käyhty, L Saarinen, C A van Boeckel, G A van der Marel, J H van Boom, J T Poolman.   

Abstract

Synthetic oligosaccharides derived from the capsular polysaccharide (PRP) of Haemophilus influenzae type b were conjugated to carrier proteins via a thioether linkage. Conjugates were made of trimeric and tetrameric ribose-ribitol-phosphate and tetanus toxoid or diphtheria toxin. All conjugates elicited anti-PRP antibody responses with an increasing immunoglobulin G/immunoglobulin M ratio in adult mice and monkeys. Trimer conjugates elicited lower anti-PRP antibody responses compared with tetramer conjugates. Adult monkeys responded equally well to the tetrameric oligosaccharide-tetanus toxoid conjugate as to the oligosaccharide-CRM197 conjugate (HbOC), which elicits protective levels of serum antibodies in human infants after two or three injections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563770      PMCID: PMC257080          DOI: 10.1128/iai.60.5.1826-1833.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.

Authors:  A A Lenoir; P D Granoff; D M Granoff
Journal:  Pediatrics       Date:  1987-08       Impact factor: 7.124

2.  Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.

Authors:  B A Claesson; R Schneerson; J B Robbins; J Johansson; T Lagergard; J Taranger; D Bryla; L Levi; T Cramton; B Trollfors
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

3.  Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.

Authors:  P W Anderson; M E Pichichero; E C Stein; S Porcelli; R F Betts; D M Connuck; D Korones; R A Insel; J M Zahradnik; R Eby
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

4.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

5.  Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan.

Authors:  R M Crisel; R S Baker; D E Dorman
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

Review 6.  Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries.

Authors:  R S Munson; M H Kabeer; A A Lenoir; D M Granoff
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults.

Authors:  D M Granoff; E G Boies; R S Munson
Journal:  J Pediatr       Date:  1984-07       Impact factor: 4.406

8.  Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.

Authors:  P Anderson; M Pichichero; K Edwards; C R Porch; R Insel
Journal:  J Pediatr       Date:  1987-11       Impact factor: 4.406

9.  Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults.

Authors:  M L Lepow; J S Samuelson; L K Gordon
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

10.  Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Authors:  R Schneerson; O Barrera; A Sutton; J B Robbins
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  17 in total

1.  Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.

Authors:  V Pozsgay; C Chu; L Pannell; J Wolfe; J B Robbins; R Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Authors:  W T Jansen; S Hogenboom; M J Thijssen; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe; A F Verheul
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 3.  In vitro antibody response of human lymphocytes to the Haemophilus influenzae type b capsular polysaccharide.

Authors:  C C Peeters; A M Tenbergen-Meekes; J T Poolman; B J Zegers; G T Rijkers
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity.

Authors:  A Midwinter; T Vinh; S Faine; B Adler
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker.

Authors:  Z Kossaczka; S Bystricky; D A Bryla; J Shiloach; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.

Authors:  Gilda Toraño; Maria E Toledo; Alberto Baly; Violeta Fernandez-Santana; Francisco Rodriguez; Yunia Alvarez; Teresita Serrano; Alexis Musachio; Ibis Hernandez; Eugenio Hardy; Arlene Rodríguez; Hector Hernandez; Aristides Aguilar; Raydel Sánchez; Manuel Diaz; Verena Muzio; Jorgelina Dfana; Maria C Rodríguez; Lazaro Heynngnezz; Vicente Verez-Bencomo
Journal:  Clin Vaccine Immunol       Date:  2006-09

7.  Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.

Authors:  K H Kim; M K Park; C C Peeters; J T Poolman; M H Shearer; R C Kennedy; M H Nahm
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Conjugation of 5-azido-3-oxapentyl glycosides with thiolated proteins through the use of thiophilic derivatives.

Authors:  V Fernández-Santana; R González-Lio; J Sarracent-Pérez; V Verez-Bencomo
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

9.  Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.

Authors:  G Ravi; Yeldur P Venkatesh
Journal:  Glycoconj J       Date:  2014-08-10       Impact factor: 2.916

Review 10.  Structure, function and immunochemistry of bacterial exopolysaccharides.

Authors:  R Weiner; S Langille; E Quintero
Journal:  J Ind Microbiol       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.